Dividend Dispatch — Today's Theme
Today's Theme
Caterpillar yields 0.70%. Pfizer yields 6.93%. Guess which one worries me.
I get this question a lot: why would anyone buy a stock that yields less than 1%? Caterpillar yields 0.70% right now. That's $70 a year on $10,000. Your savings account does better. But CAT just raised its dividend 8%, has done it 32 years straight, and goes ex-dividend Monday. Meanwhile, Pfizer yields 6.93% — and is paying out more than it earns. Today I've got two dividend growth names with serious raising power, plus two safety calls — JNJ, which just crushed Q2 earnings yesterday behind 64 straight years of raises, and PFE, where the math under that 7% yield gets ugly fast.

While everyone was distracted with the recent SpaceX IPO…

Elon Musk quietly filed a patent with the U.S. Patent and Trademark Office to protect what Jeff Brown believes will be his next breakthrough…

Something he called "the greatest tech invention in history."

Click here to see the details because Elon is predicting this new AI breakthrough will unleash a $1 quadrillion new wealth wave.

Dividend Dispatch — Section 1a
🚀
Dividend Growth Stars
Fast-rising income builders
CATCaterpillar just raised 8% — and if you want the new rate, you have until tomorrow
Caterpillar makes the giant yellow machines that dig mines, build highways, and level construction sites all over the world. You know the brand. Here's what you might not know: CAT has raised its dividend for 32 consecutive years. On June 10, the board hiked it 8% — from $1.51 to $1.63 per quarter. That's $6.52 a year at the new rate.

And here's where timing matters. The ex-dividend date — that's the cutoff to buy and still qualify for the next payment — is Monday, July 20. With T+1 settlement (trades now settle the next business day), the last day to buy and still be a shareholder of record is tomorrow, Friday the 17th. If you buy Monday, you're too late for this round.

I know 0.70% looks tiny. But at 8% annual raises, your yield-on-cost doubles in about nine years. Five years from now, that 0.70% becomes roughly 1.03%. Ten years out, 1.51%. You're not buying today's yield — you're buying the trajectory.

The risk: Caterpillar is deeply cyclical. When construction and mining slow down, earnings drop hard. And the stock has more than doubled from its 52-week low around $403 — there's real valuation risk if the industrial cycle turns.
Yield: 0.70% $10K invested = $70/yr Paid: Quarterly
Dividend Dispatch — Section 1b
MSCIMSCI raised 14% — and its payout ratio is only 43%
Here's a company most people have never heard of, even though their money almost certainly touches it. MSCI Inc. creates the indexes that trillions of dollars in global investment funds track. When your 401(k) holds an “international” or “emerging markets” fund, there's a good chance it's benchmarked to an MSCI index. Fund managers pay MSCI recurring licensing fees to use those indexes. Think of it as a toll booth on the global investment highway.

The dividend growth here is exceptional. MSCI raised 13.9% for 2026, bringing the quarterly payout to $2.05 — that's $8.20 a year. The five-year average growth rate is roughly 20% per year. And the payout ratio? Just 43%. There's enormous room to keep raising.

OK so here's a concept I love explaining: yield-on-cost. MSCI yields 1.34% today. But if the dividend keeps growing at 20% a year, that 1.34% on your original purchase price becomes 3.3% in five years and 8.3% in ten. You bought it at 1.3%. The stock hands you 8.3%. The market just can't see that far ahead.

The risk: MSCI's revenue is tied to global assets under management. A prolonged bear market means less AUM, fewer licensing fees, and slower growth. At roughly 28x forward earnings, you're paying up for quality. And MSCI reports Q2 earnings next Tuesday, July 21 — any miss could rattle the stock short-term.
Yield: 1.34% $10K invested = $134/yr Paid: Quarterly
Dividend Dispatch — Main Rest
🛡️
Safety & Watchlist
Reliable picks + red flags
Safe Pick
JNJJNJ just beat earnings and raised guidance — 64 straight years of raises
Johnson & Johnson reported Q2 results yesterday — $25.3 billion in revenue, up 6.6%, with adjusted earnings of $2.90 per share. They raised full-year guidance to $11.68 EPS at the midpoint. And this is a company that has increased its dividend for 64 consecutive years. Since 1963. Since Kennedy was in the White House.

The quarterly payout is $1.34, giving you $5.36 a year per share. At around $254, that's a 2.11% yield. Not flashy, but JNJ is a Dividend King — that's a company with 50 or more consecutive years of increases. Only a handful of companies on Earth qualify. JNJ is now on track to hit $100 billion in annual revenue for the first time in its 140-year history.

This is the kind of name I put in the “never think about it again” part of my portfolio. With a payout ratio well under 50% on adjusted earnings, the dividend is covered with room to spare.
Yield: 2.11% $10K invested = $211/yr Paid: Quarterly
Red Flag
PFEPfizer yields 6.93% — and pays out more than it earns
I know a lot of people own Pfizer for the yield. At $24.82, with a $1.72 annual dividend, PFE yields 6.93%. That's $693 a year on $10,000. Sounds incredible next to CAT's $70 or JNJ's $211.

But here's the number that keeps me up: Pfizer's GAAP payout ratio is 130.5%. For every dollar they earn, they're sending $1.30 out the door in dividends. That's like a pizza shop where the delivery costs more than the pizza — it can work for a while, but not forever.

Management says adjusted 2026 EPS will be $2.80–$3.00, which would put the adjusted payout ratio around 60%. But “adjusted” earnings strip out a lot of real costs. And the patent cliff is real — key drugs are losing exclusivity, and replacing that revenue is like running up a down escalator. It's possible, but you have to run fast.

The ex-dividend date is July 24 — next Friday. If you own PFE, I'm not saying sell. But watch the free cash flow number closely in the next earnings report. If FCF can't cover the dividend, that 6.93% yield is living on borrowed time.
📋
The Extra Yield
This week's calendars, screens & answers
Don't miss these ex-dates: CAT goes ex-dividend Monday July 20 at the new $1.63 rate. Procter & Gamble (PG) also goes ex July 24 at $1.0885. Pfizer (PFE) goes ex July 24 at $0.43. If you own any of these and want the next payment, make sure you're holding before the ex-date.
I ran a screen this morning: Cintas (CTAS) — the company that supplies uniforms and first-aid kits to businesses — reported blowout fiscal Q4 results yesterday. Revenue up 8.9% to $2.91 billion. Adjusted EPS grew 18.3%. The payout ratio is just 35%. Not a household name, but one of the steadiest dividend growers in the S&P 500.
Someone asked me: “What happens if I buy CAT on Monday the 20th instead of Friday?” You'd miss this quarter's $1.63 payment. The ex-dividend date is the cutoff — buy before it, you get paid. Buy on or after it, you wait until next quarter. For CAT, that means waiting until November.
The Dispatch
Today was about which direction the yield is heading. Caterpillar and MSCI are growing their payouts at 8% and 20% a year — small yields today, but they won't stay small. JNJ just proved again why 64 years means something. And Pfizer's 6.93% yield deserves a harder look at the math underneath. Tomorrow I'll tie the whole week together in the Friday roundup. Have a good Thursday night.

See you tomorrow.
— Charlie

Recommended publications

View more
caret-right